HLB
LSKB
HLBLS
LSKI
LIFELIVER
SHINHWA
HWAJIN
About
Who We Are
Vision
Leadership
Pipeline
Comprehensive Pipeline
Targeted Therapy
Cell Therapy
Medical Device
Media
News
Notice
Contact
Family Sites
HLB
LSKB
HLBLS
LSKI
LIFELIVER
SHINHWA
HWAJIN
English
Korean
Korean
Pipeline
Pipeline
About
Pipeline
Media
Contact
Comprehensive Pipeline
Comprehensive Pipeline
Targeted Therapy
Cell Therapy
Medical Device
Comprehensive Pipeline
Therapeutic Area
Product
Indications
Feasibility
Non-clinical
PhaseⅠ
PhaseⅡ
PhaseⅢ
Remarks
Targeted Therapy
Rivoceranib (VEGFR-2)
위암 3차 단독 (GC 3rd line Mono)
간암 1차 병용 (HCC 1st line Camrelizumab combo)
항서제약과 공동개발 (다국가)
선낭암종 1차 단독 (ACC 1st line Mono)
고형암 병용 (I/O Combo-Nivolumab, Pembrolizumab)
위암 2차 병용 (GC 2nd line Taxane Combo)
대장암 3차 병용 (CRC 3rd line TAS-102 Combo)
급성 황반 변성 (Acute Macular Degeneration)
동물용 항암제 (Canine/Feline Solid Tumor and Hematology)
Tegavivint (WNT/β-Catenin)
공격성 섬유종증 (Desmoid Tumor)
이테리온 테라퓨틱스 진행 중 (미국)
Seclidemstat (LSD-1)
유잉육종 (Ewing Sarcoma)
살라리우스 제약 진행 중 (미국)
Cell Therapy
Lifeliver™ (Bio Artificial Liver)
급성 만성 간부전 (Acute Liver Failure)
Hepastem (Cell Therapeutics)
요소회로 이상증 (Urea Cycle Disorder, UCD)
급만성간부전 (Acute-on-Chronic Liver Failure, ACLF)
프로메세라 바이오사이언스 진행 중 (다국가)
비알콜성지방간 (Non-Alchoholic Steato-Hepatitis, NASH)
프로메세라 바이오사이언스 진행 중 (다국가)
Medical Device
HLBLS-200 (Hemostat)
수술용 지혈제 (Surgical Hemostat)
doChangeLangType('en');